These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2521267)

  • 1. Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow.
    Baim DS
    Am J Cardiol; 1989 Jan; 63(2):23A-26A. PubMed ID: 2521267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of amrinone on myocardial energetics in severe congestive heart failure.
    Baim DS
    Am J Cardiol; 1985 Jul; 56(3):16B-18B. PubMed ID: 3161318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
    Zausig YA; Stowe DF; Zink W; Grube C; Martin E; Graf BM
    Anesth Analg; 2006 Jun; 102(6):1646-52. PubMed ID: 16717301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
    Rump AF; Acar D; Klaus W
    Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
    Vandeplassche GM; Hermans CF; de Chaffoy de Courcelles DR; D'Aubioul JA; Wouters LJ; De Clerck FF
    J Cardiovasc Pharmacol; 1992 May; 19(5):714-22. PubMed ID: 1381769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitors: alterations in systemic and coronary hemodynamics.
    Chatterjee K
    Basic Res Cardiol; 1989; 84 Suppl 1():213-24. PubMed ID: 2684145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myocardial energetics in patients with dilated cardiomyopathy. Influence of nitroprusside and enoximone.
    Hasenfuss G; Holubarsch C; Heiss HW; Meinertz T; Bonzel T; Wais U; Lehmann M; Just H
    Circulation; 1989 Jul; 80(1):51-64. PubMed ID: 2525432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term assessment of left ventricular function, coronary hemodynamics, and catecholamine balance in severe congestive heart failure after a single oral dose of milrinone.
    Piscione F; Jaski BE; Serruys PW
    J Cardiovasc Pharmacol; 1988 Mar; 11(3):258-69. PubMed ID: 2452918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milrinone, a cyclic AMP-phosphodiesterase inhibitor, has differential effects on regional myocardial work and oxygen consumption in experimental left ventricular hypertrophy.
    Chiu WC; Kedem J; Weiss HR; Tse J; Cheinberg BV; Scholz PM
    Cardiovasc Res; 1994 Sep; 28(9):1360-5. PubMed ID: 7954646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral and cardiac effects of a new phosphodiesterase inhibitor in comparison with enoximone.
    Schröder T; Hering JP; Foth H; Ferrari M; Sipinková I; Hellige G
    Arzneimittelforschung; 1994 Aug; 44(8):948-50. PubMed ID: 7945538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of milrinone (Win 47203) on the coronary blood flow and oxygen consumption of the dog heart-lung preparation.
    Kabela E; Barcenas L; Farah A
    Am Heart J; 1986 Apr; 111(4):702-9. PubMed ID: 3953393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES; Baim DS; Smith HS; Lanoue A; Brauwald E; Grossman W
    Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
    Holubarsch C; Hasenfuss G; Heiss WH; Just H
    Am J Cardiol; 1988 Sep; 62(8):104E-107E. PubMed ID: 2970783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in left ventricular function, coronary hemodynamics and myocardial catecholamine balance with MDL 17043, a new inotropic vasodilator agent, in patients with severe heart failure.
    Viquerat CE; Kereiakes D; Morris DL; Daly PA; Wexman M; Frank P; Parmley WW; Chatterjee K
    J Am Coll Cardiol; 1985 Feb; 5(2 Pt 1):326-32. PubMed ID: 3155761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial energetics in dilated cardiomyopathy.
    Thierfelder L; Holubarsch CH; Hasenfuss G; Just HJ
    Clin Cardiol; 1990 Sep; 13(9):649-54. PubMed ID: 1976466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in myocardial metabolism induced by drugs used during intensive care].
    Lançon JP; Leneuf P; Rerolle A; Caillard B
    Ann Fr Anesth Reanim; 1990; 9(1):31-41. PubMed ID: 1970463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine, dobutamine, amrinone and milrinone on regional blood flow in isoflurane anesthetized dogs.
    Tobata D; Takao K; Mochizuki M; Nishimura R; Sasaki N
    J Vet Med Sci; 2004 Sep; 66(9):1097-105. PubMed ID: 15472474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New positive inotropic drugs].
    Lehot JJ
    Ann Fr Anesth Reanim; 1991; 10(1):62-9. PubMed ID: 1672585
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of fatty acid oxidation in myocytes by phosphodiesterase inhibitors and adenosine analogues.
    Abdel-Aleem S; Badr M; Frangakis C
    Life Sci; 1991; 48(18):PL97-102. PubMed ID: 1708436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of amrinone and milrinone on myocardial ischemia extent and infarct size in isolated rabbit hearts.
    Rump AF; Blazincic B; Klaus W
    Arzneimittelforschung; 1993 Dec; 43(12):1262-6. PubMed ID: 8141811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.